Silo Pharma | ARS: Annual Report to Security Holders
Silo Pharma | DEFA14A: Others
Silo Pharma | DEF 14A: Definitive information statements
Silo Pharma | 8-K: Current report
Silo Pharma | 424B3: Prospectus
Silo Pharma | EFFECT: Others
Silo Pharma | CORRESP: CORRESP
Silo Pharma | UPLOAD: Others
Silo Pharma | S-1: General form for registration of securities under the Securities Act of 1933
Silo Pharma | 10-Q: Q2 2024 Earnings Report
Silo Pharma | D: Filing D
Silo Pharma | 424B3: Prospectus
Silo Pharma | EFFECT: Others
Silo Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Mitchell P. Kopin(4.99%),Daniel B. Asher(4.99%), etc.
Silo Pharma | CORRESP: CORRESP
Silo Pharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Silo Pharma | 8-K: Current report
Silo Pharma | UPLOAD: Others
Silo Pharma | 424B5: Prospectus
Silo Pharma | S-1: General form for registration of securities under the Securities Act of 1933
No Data
No Data